LoginGet started
Picture of Biolog Device Co logo

208710 — Biolog Device Co Income Statement

0.000.00%
kr flag iconLast trade - 00:00
TechnologyHighly SpeculativeMicro CapValue Trap
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual income statement for Biolog Device Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
R2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue90,41991,79387,280104,283123,469
Cost of Revenue
Gross Profit19,7024,2953,9388,6004,611
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses83,51396,83685,154104,479127,437
Operating Profit6,906-5,0432,126-196-3,968
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes7,028-16,522-9,1674,888-7,833
Provision for Income Taxes
Net Income After Taxes6,135-16,895-7,8871,820-7,989
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income6,146-16,895-7,214257-11,810
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income6,797-16,895-7,214257-11,810
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS207-573-340-26.8-115
Dividends per Share